RecruitingHepatocellular CarcinomaCirrhosis, LiverHepatitis B
Liver Cancer Disparities in American Indian and Alaska Native Persons
Eligible age
18–75 yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
We are performing a pilot and feasibility randomized controlled trial (RCT) of HCC screening by US + AFP every 6 months (n=100), the current standard-of-care, versus aMRI + AFP every 6 months (n=100) for 12 months (i.e. at time 0, 6 and 12 months) among AI/AN patients with cirrhosis or HBV.
Sponsor: University of Washington
You may qualify if…
- ✓ Cirrhosis, any etiology, or chronic HBV infection
- ✓ High risk of HCC
- ✓ Age 18-75
- ✓ Competent to provide informed consent
You may not qualify if…
- ✕ Prior diagnosis of HCC
- ✕ Current suspicion of HCC
- ✕ Prior receipt of any organ transplantation
- ✕ Participation in another HCC screening trial
- ✕ CTP score \>=10
- ✕ MELD-Na score \>20
- ✕ GFR\<30
- ✕ Poor life expectancy (\<5 years)
Where it's recruiting
Oklahoma
Tahlequah
Source: ClinicalTrials.gov · NCT05304234 · last updated 2024-06-04